We serve Chemical Name:4,4-Difluorocyclohexanol CAS:22419-35-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4,4-Difluorocyclohexanol
CAS.NO:22419-35-8
Synonyms:4,4-DIFLUORO-CYCLOHEXANOL;4,4-Difluor-cyclohexanol;1,1-Difluorocyclohexan-4-ol;4,4-Difluorocyclohexanol;Cyclohexanol, 4,4-difluoro-;1,1-Difluoro-4-hydroxycyclohexane
Molecular Formula:C6H10F2O
Molecular Weight:136.140
HS Code:2906199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:160.6±40.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.414
PSA:20.23000
Exact Mass:136.069977
LogP:0.43
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like 4,4-DIFLUORO-CYCLOHEXANOL chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,1-Difluoro-4-hydroxycyclohexane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Cyclohexanol, 4,4-difluoro- Use and application,4,4-Difluor-cyclohexanol technical grade,usp/ep/jp grade.
Related News: FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus. 4,4-Difluorocyclohexanol manufacturer The complete chemical and pharmaceutical industry chain consists of basic chemical raw materials, pharmaceutical intermediates, chemical raw materials and chemical preparations. 4,4-Difluorocyclohexanol supplier FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus. 4,4-Difluorocyclohexanol vendor FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus. 4,4-Difluorocyclohexanol factory Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.
